|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 18, 2018 ) According to Verified Market Intelligence, the global clinical trial imaging market was valued at USD 772.9 Million in 2016 and is projected to reach USD 1,294.75 Million by 2025, growing at a CAGR of 5.9% from 2016 to 2025.
The clinical trial is an essential part of the drug development process and the usage of medical imaging makes the clinical trials more accurate and effective. Clinical trial imaging provides the interpretable information of human anatomy/ physiology which is important in evaluating effect of drugs. It is mainly useful in the prevention, detection, and treatment of various medical conditions.
Click Here To Download Free Sample Copy @ https://bit.ly/2D03lvQ
Increase in pharma and biotech industries, increase in investments in R&D department and emerging economies in industry are the driving factors for the global clinical trial imaging market. While high cost of instalment and high cost of clinical trials acts a potential restraints for the overall market at a global level.
Competitive Landscape:
The major players in the market are as follows:
Bioclinica, Inc.
Parexel International Corporation
Icon PLC
Biomedical Systems Corporation
Biotelemetry, Inc.
Cardiovascular Imaging Technologies, LLC
Intrinsic Imaging LLC
Ixico PLC
Radiant Sage LLC
Worldcare Clinical, LLC
Ask For Discount @ https://bit.ly/2Dcvtft
About Us:
Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.
Contact Information:
Verified Market Research
Contact Person: Ankush
Tel: +1650781 4080
Email us: sales@verifiedmarketresearch.com
Verified Market Research
Amaan Kazi
+1 (650) 781 4080
amaankazi@verifiedmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
